Apellis Pharmaceuticals Inc. logo

Apellis Pharmaceuticals Inc. (APLS)

Delisted
15 May 2026
NASDAQ (NGS) NASDAQ (NGS)
$
41. 03
0
0%
$
5.25B Market Cap
- P/E Ratio
- Div Yield
28.64M Volume
-4.51 Eps
$ 41.03
Previous Close
Day Range
41.03 41.05
Year Range
16.61 41.14
Want to track APLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Apellis Pharmaceuticals Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
6,977 $175,262.27 $286,266.31 $111,004.04 63.34%
EPI
Evelyn Partners Investment Management LLP Evelyn Partners Investment Management LLP
150 $3,280.5 $6,154.5 $2,874 87.61%
Nicole Reese
Nicole Reese WPG Advisers LLC
5 $160 $205.15 $45.15 28.22%
United Financial Planning Group LLC
United Financial Planning Group LLC United Financial Planning Group LLC
24 $603 $984.72 $381.72 63.3%
Jon Borer
Jon Borer Capitolis Liquid Global Markets LLC
1.01M $40.77M $41.58M $810,800 1.99%